Voluntary announcement - purchase of shares by the trustee for the purpose of the 2022 rsu scheme
Filed with HKEX · Stock code 6855 ·
6ix is reading this filing.
View original source (HKEXnews)Ascentage Pharma Group International on 6ix
Earlier from Ascentage Pharma Group International
- Voluntary announcement - Ascentage Pharma's lisaftoclax granted breakthrough therapy designation in china for treatment-naive cll/sll
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement - acquisition of shares by the chairman and executive director
- Interim report 2026
- Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
Follow Ascentage Pharma Group International into a list and get an email when it puts out news.
Follow Ascentage Pharma Group International